Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
X-box binding protein 1 pseudogene 1 (XBP1P1) is a genomic DNA sequence similar to the X-box binding protein 1 (XBP1) gene but is classified as a pseudogene and does not encode a functional protein[1][3]. While XBP1 is a well-characterized transcription factor involved in the unfolded protein response (UPR), immune signaling, cancer, and other disease mechanisms, the pseudogene XBP1P1 has no established biological function, disease role, or relevance as a therapeutic target. The existence of XBP1P1 is mainly noted on annotated gene databases as a sequence homologous to XBP1 localized to chromosome 5[1][3]. Information on alternative names and any functional role for XBP1P1 is currently absent from mainstream biomedical literature. Important distinction: XBP1 (not XBP1P1) is a validated transcription factor, highly studied as a gene/protein therapeutic target in multiple conditions (e.g., cancer, metabolic disease, cardiovascular disease)[1][2][3][4][6]. XBP1P1 is a pseudogene and is not considered a therapeutic target, receptor, enzyme, or transporter.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on X-box binding protein 1 pseudogene 1 (XBP1P1).